Sarepta Therapeutics (SRPT) Amortizatization of Intangibles (2014 - 2026)
Sarepta Therapeutics' quarterly Amortizatization of Intangibles came in at -$530000.0 in Q1 2026, up 72.28% year-on-year from -$307638.1 in Q1 2025, and down 39.47% quarter-over-quarter from -$380000.0 in Q4 2025.
Sarepta Therapeutics has reported Amortizatization of Intangibles for 10 years, with the latest figure at -$530000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 72.28% year-over-year to -$530000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.9 million (up 86.88% YoY), and the FY2025 full-year result was -$5.3 million, up 86.86% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$530000.0, down from -$380000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was -$50000.0 in Q1 2022, with the low at -$13.3 million in Q4 2023.
- Average Amortizatization of Intangibles over 5 years is -$6.1 million, with a median of -$6.1 million recorded in 2022.
- Year-over-year, Amortizatization of Intangibles tumbled 17202.0% in 2023 and soared 94.41% in 2025.
- Tracing SRPT's Amortizatization of Intangibles over 5 years: stood at -$6.1 million in 2022, then sank by 117.33% to -$13.3 million in 2023, then surged by 48.96% to -$6.8 million in 2024, then soared by 94.41% to -$380000.0 in 2025, then sank by 39.47% to -$530000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at -$530000.0 (Q1 2026), -$380000.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -530,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -530,000.00 |
| Mar 31, 2026 | -530,000.00 |
| Dec 31, 2025 | -380,000.00 |
| Dec 31, 2025 | -380,000.00 |
| Sep 30, 2025 | -1.13 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -1.87 Mn |
| Jun 30, 2025 | -1.87 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Sep 30, 2024 | -10.62 Mn |
| Sep 30, 2024 | -10.62 Mn |
| Jun 30, 2024 | -10.46 Mn |
| Jun 30, 2024 | -10.46 Mn |
| Mar 31, 2024 | -12.40 Mn |
| Mar 31, 2024 | -12.40 Mn |
| Dec 31, 2023 | -13.33 Mn |
| Dec 31, 2023 | -13.33 Mn |
| Sep 30, 2023 | -12.60 Mn |
| Sep 30, 2023 | -12.60 Mn |
| Jun 30, 2023 | -11.59 Mn |
| Jun 30, 2023 | -11.59 Mn |
| Mar 31, 2023 | -8.65 Mn |
| Mar 31, 2023 | -8.65 Mn |
| Dec 31, 2022 | -6.13 Mn |
| Dec 31, 2022 | -6.13 Mn |
| Sep 30, 2022 | -3.06 Mn |
| Sep 30, 2022 | -3.06 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | -50,000.00 |
| Mar 31, 2022 | -50,000.00 |
| Jun 30, 2018 | 1.57 Mn |
| Jun 30, 2018 | 1.57 Mn |
| Mar 31, 2018 | 1.26 Mn |
| Mar 31, 2018 | 1.26 Mn |
| Dec 31, 2017 | 744,000.00 |
| Dec 31, 2017 | 744,000.00 |
| Sep 30, 2017 | -116,000.00 |
| Sep 30, 2017 | -116,000.00 |
| Jun 30, 2017 | 160,000.00 |
| Jun 30, 2017 | 160,000.00 |
| Mar 31, 2017 | 100,000.00 |
| Mar 31, 2017 | 100,000.00 |
| Dec 31, 2016 | 393,000.00 |
| Dec 31, 2016 | 393,000.00 |
| Sep 30, 2016 | -867,000.00 |
| Sep 30, 2016 | -867,000.00 |
| Jun 30, 2016 | 152,000.00 |
| Jun 30, 2016 | 152,000.00 |
| Mar 31, 2016 | 242,000.00 |
| Mar 31, 2016 | 242,000.00 |
| Dec 31, 2015 | -1.46 Mn |
| Dec 31, 2015 | -1.46 Mn |
| Sep 30, 2015 | 192,000.00 |
| Sep 30, 2015 | 192,000.00 |
| Jun 30, 2015 | 298,000.00 |
| Jun 30, 2015 | 298,000.00 |
| Mar 31, 2015 | 315,000.00 |
| Mar 31, 2015 | 315,000.00 |
| Dec 31, 2014 | 584,000.00 |
| Dec 31, 2014 | 584,000.00 |
| Sep 30, 2014 | 721,000.00 |
| Sep 30, 2014 | 721,000.00 |
| Jun 30, 2014 | 608,000.00 |
| Jun 30, 2014 | 608,000.00 |
| Mar 31, 2014 | 519,000.00 |
| Mar 31, 2014 | 519,000.00 |